These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 26744321)

  • 1. Type 2 diabetes-induced neuronal pathology in the piriform cortex of the rat is reversed by the GLP-1 receptor agonist exendin-4.
    Lietzau G; Nyström T; Östenson CG; Darsalia V; Patrone C
    Oncotarget; 2016 Feb; 7(5):5865-76. PubMed ID: 26744321
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diabetes negatively affects cortical and striatal GABAergic neurons: an effect that is partially counteracted by exendin-4.
    Larsson M; Lietzau G; Nathanson D; Östenson CG; Mallard C; Johansson ME; Nyström T; Patrone C; Darsalia V
    Biosci Rep; 2016 Dec; 36(6):. PubMed ID: 27780892
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Type 2 diabetes impairs odour detection, olfactory memory and olfactory neuroplasticity; effects partly reversed by the DPP-4 inhibitor Linagliptin.
    Lietzau G; Davidsson W; Östenson CG; Chiazza F; Nathanson D; Pintana H; Skogsberg J; Klein T; Nyström T; Darsalia V; Patrone C
    Acta Neuropathol Commun; 2018 Feb; 6(1):14. PubMed ID: 29471869
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Brain GLP-1/IGF-1 Signaling and Autophagy Mediate Exendin-4 Protection Against Apoptosis in Type 2 Diabetic Rats.
    Candeias E; Sebastião I; Cardoso S; Carvalho C; Santos MS; Oliveira CR; Moreira PI; Duarte AI
    Mol Neurobiol; 2018 May; 55(5):4030-4050. PubMed ID: 28573460
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exendin-4 attenuates neuronal death via GLP-1R/PI3K/Akt pathway in early brain injury after subarachnoid hemorrhage in rats.
    Xie Z; Enkhjargal B; Wu L; Zhou K; Sun C; Hu X; Gospodarev V; Tang J; You C; Zhang JH
    Neuropharmacology; 2018 Jan; 128():142-151. PubMed ID: 28986282
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exendin-4, a glucagon-like peptide-1 receptor agonist, reduces Alzheimer disease-associated tau hyperphosphorylation in the hippocampus of rats with type 2 diabetes.
    Xu W; Yang Y; Yuan G; Zhu W; Ma D; Hu S
    J Investig Med; 2015 Feb; 63(2):267-72. PubMed ID: 25479064
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Preparation and the biological effect of fusion protein GLP-1-exendin-4/ IgG4(Fc) fusion protein as long acting GLP-1 receptor agonist].
    Zheng YC
    Yao Xue Xue Bao; 2015 Dec; 50(12):1668-72. PubMed ID: 27169293
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exendin-4 reduces tau hyperphosphorylation in type 2 diabetic rats via increasing brain insulin level.
    Yang Y; Ma D; Xu W; Chen F; Du T; Yue W; Shao S; Yuan G
    Mol Cell Neurosci; 2016 Jan; 70():68-75. PubMed ID: 26640240
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Normalisation of glucose metabolism by exendin-4 in the chronic phase after stroke promotes functional recovery in male diabetic mice.
    Augestad IL; Dekens D; Karampatsi D; Elabi O; Zabala A; Pintana H; Larsson M; Nyström T; Paul G; Darsalia V; Patrone C
    Br J Pharmacol; 2022 Feb; 179(4):677-694. PubMed ID: 33973246
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exendin-4 protects retinal cells from early diabetes in Goto-Kakizaki rats by increasing the Bcl-2/Bax and Bcl-xL/Bax ratios and reducing reactive gliosis.
    Fan Y; Liu K; Wang Q; Ruan Y; Zhang Y; Ye W
    Mol Vis; 2014; 20():1557-68. PubMed ID: 25489228
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exendin-4 exerts osteogenic actions in insulin-resistant and type 2 diabetic states.
    Nuche-Berenguer B; Moreno P; Portal-Nuñez S; Dapía S; Esbrit P; Villanueva-Peñacarrillo ML
    Regul Pept; 2010 Jan; 159(1-3):61-6. PubMed ID: 19586609
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peptidic exenatide and herbal catalpol mediate neuroprotection via the hippocampal GLP-1 receptor/β-endorphin pathway.
    Jia Y; Gong N; Li TF; Zhu B; Wang YX
    Pharmacol Res; 2015 Dec; 102():276-85. PubMed ID: 26546042
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exenatide upregulates gene expression of glucagon-like peptide-1 receptor and nerve growth factor in streptozotocin/nicotinamide-induced diabetic mice.
    Gumuslu E; Cine N; Ertan M; Mutlu O; Komsuoglu Celikyurt I; Ulak G
    Fundam Clin Pharmacol; 2018 Apr; 32(2):174-180. PubMed ID: 29091313
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recombinant Lactococcus lactis expressing bioactive exendin-4 to promote insulin secretion and beta-cell proliferation in vitro.
    Zeng Z; Yu R; Zuo F; Zhang B; Ma H; Chen S
    Appl Microbiol Biotechnol; 2017 Oct; 101(19):7177-7186. PubMed ID: 28828521
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of exendin-4 and selenium on the expression of GLP-1R, IRS-1, and preproinsulin in the pancreas of diabetic rats.
    Barakat G; Moustafa ME; Khalifeh I; Hodroj MH; Bikhazi A; Rizk S
    J Physiol Biochem; 2016 Aug; 73(3):387-394. PubMed ID: 28589533
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of type 2 diabetes mellitus with agonists of the GLP-1 receptor or DPP-IV inhibitors.
    Holst JJ
    Expert Opin Emerg Drugs; 2004 May; 9(1):155-66. PubMed ID: 15155141
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The GLP-1 receptor agonists exendin-4 and liraglutide alleviate oxidative stress and cognitive and micturition deficits induced by middle cerebral artery occlusion in diabetic mice.
    Li PC; Liu LF; Jou MJ; Wang HK
    BMC Neurosci; 2016 Jun; 17(1):37. PubMed ID: 27296974
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exendin-4, a glucagon-like peptide-1 receptor agonist, inhibits cell apoptosis induced by lipotoxicity in pancreatic β-cell line.
    Wei Q; Sun YQ; Zhang J
    Peptides; 2012 Sep; 37(1):18-24. PubMed ID: 22776329
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exenatide exerts a PKA-dependent positive inotropic effect in human atrial myocardium: GLP-1R mediated effects in human myocardium.
    Wallner M; Kolesnik E; Ablasser K; Khafaga M; Wakula P; Ljubojevic S; Thon-Gutschi EM; Sourij H; Kapl M; Edmunds NJ; Kuzmiski JB; Griffith DA; Knez I; Pieske B; von Lewinski D
    J Mol Cell Cardiol; 2015 Dec; 89(Pt B):365-75. PubMed ID: 26432951
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exenatide exerts direct protective effects on endothelial cells through the AMPK/Akt/eNOS pathway in a GLP-1 receptor-dependent manner.
    Wei R; Ma S; Wang C; Ke J; Yang J; Li W; Liu Y; Hou W; Feng X; Wang G; Hong T
    Am J Physiol Endocrinol Metab; 2016 Jun; 310(11):E947-57. PubMed ID: 27072494
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.